0001140361-14-014270.txt : 20140326 0001140361-14-014270.hdr.sgml : 20140326 20140326140440 ACCESSION NUMBER: 0001140361-14-014270 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140325 FILED AS OF DATE: 20140326 DATE AS OF CHANGE: 20140326 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taurus4757 GmbH CENTRAL INDEX KEY: 0001603397 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 14718275 BUSINESS ADDRESS: STREET 1: WISSMANNSTRASSE 15 CITY: ZURICH STATE: V8 ZIP: CH 8057 BUSINESS PHONE: 414 43620406 MAIL ADDRESS: STREET 1: WISSMANNSTRASSE 15 CITY: ZURICH STATE: V8 ZIP: CH 8057 3 1 doc1.xml FORM 3 X0206 3 2014-03-25 0 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001603397 Taurus4757 GmbH WISSMANNSTRASSE 15 ZURICH V8 CH 8057 SWITZERLAND 0 0 1 0 Common Stock 1544194 D Common Stock Warrants 4.75 2014-03-25 2021-03-25 Common Shares 1544194 D Units consisting of common stock and warrants were issued to the Reporting Person in connection with the conversion of outstanding promissory notes and interest accrued thereon. Each unit acquired in the conversion consisted of 1 common stock and 1 common stock warrant. The acquisition of these securities resulted in the Reporting Person becoming a 10% owner of the Issuer. The Reporting Person is owned by Thomas Girschweiler, who has also reported these securities on a Form 4. /s/ Thomas Girschweiler, Managing Partner 2014-03-25